These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17530309)

  • 21. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
    Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
    Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.
    Cobden D; Lee WC; Balu S; Joshi AV; Pashos CL
    Pharmacotherapy; 2007 Jul; 27(7):948-62. PubMed ID: 17594200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [LAPTOP trial--results of an health economics evaluation].
    Dippel FW
    Dtsch Med Wochenschr; 2008 Aug; 133 Suppl 4():S115-9; discussion S124-6. PubMed ID: 18686220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of treatment costs in inadequately controlled type 2 diabetes in Germany based on the APOLLO trial with insulin glargine.
    Bretzel RG; Dippel FW; Linn T; Neilson AR
    J Med Econ; 2009 Jun; 12(2):87-97. PubMed ID: 19473110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin glargine in combination with oral antidiabetic drugs as a cost-equivalent alternative to conventional insulin therapy in type 2 diabetes mellitus.
    Lechleitner M; Roden M; Haehling E; Mueller M
    Wien Klin Wochenschr; 2005 Sep; 117(17):593-8. PubMed ID: 16395988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
    Simons WR; Hagan MA
    Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Redefining insulin therapy in type 2 diabetes mellitus.
    Rosenstock J
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):21-9. PubMed ID: 19667676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cost-effectiveness analysis on continuous subcutaneous insulin infusion and multi-point daily insulin injections in the treatment program of type 2 diabetes].
    Shu J; Zeng LY; Mu PW; Wang MM; Zhang GC; Chen YM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jul; 30(7):737-9. PubMed ID: 19957604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combination therapy of metformin vs dipeptidulpeptidase inhibitors and sulfonylureas in type 2 diabetes: clinical and economic impact].
    Sicras-Mainar A; Navarro-Artieda R
    Rev Peru Med Exp Salud Publica; 2014; 31(4):626-34. PubMed ID: 25597711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Costs of diabetes care and treatment satisfaction in type 2 diabetes patients treated with a basal-bolus (ICT) insulin regimen in outpatient care: results of the LIVE-COM study].
    Bierwirth RA; Kohlmann T; Moock J; Holle R; Landgraf W
    Med Klin (Munich); 2010 Nov; 105(11):792-801. PubMed ID: 21136237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes.
    Clements MR; Tits J; Kinsley BT; Råstam J; Friberg HH; Ligthelm RJ
    Diabetes Obes Metab; 2008 Mar; 10(3):229-37. PubMed ID: 18269638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany.
    Pscherer S; Dietrich ES; Dippel FW; Neilson AR
    Ger Med Sci; 2010 Aug; 8():. PubMed ID: 20725588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004.
    Patel H; Srishanmuganathan J; Car J; Majeed A
    J Public Health (Oxf); 2007 Mar; 29(1):48-52. PubMed ID: 17124257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct healthcare costs of patients with type 2 diabetes using long-acting insulin analogues or NPH insulin in a basal insulin-only regimen.
    Gundgaard J; Christensen TE; Thomsen TL
    Prim Care Diabetes; 2010 Oct; 4(3):165-72. PubMed ID: 20452847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is fenofibrate a cost-saving treatment for middle-aged individuals with type II diabetes? An economic analysis of the FIELD Study.
    Carrington M; Stewart S
    Int J Cardiol; 2008 Jun; 127(1):51-6. PubMed ID: 17586072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The economic effect of hypoglycemia in a health plan.
    Heaton A; Martin S; Brelje T
    Manag Care Interface; 2003 Jul; 16(7):23-7. PubMed ID: 12908214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Are the short-acting insulin analogs superfluous?].
    Arand M
    MMW Fortschr Med; 2006 Mar; 148(11):17. PubMed ID: 16612957
    [No Abstract]   [Full Text] [Related]  

  • 39. Insulin glargine added to therapy with oral antidiabetic agents improves glycemic control and reduces long-term complications in patients with type 2 diabetes - a simulation with the Diabetes Mellitus Model (DMM).
    Janka HU; Hessel F; Walzer S; Mã Ller E
    Int J Clin Pharmacol Ther; 2007 Dec; 45(12):623-30. PubMed ID: 18184530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral antidiabetic therapy].
    Schneider S; Pazdzierny G; Klein HH
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S264-7. PubMed ID: 17139584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.